Antera pulls in $1.7 mln seed

By Iris Dorbian — 11 months ago

Antera Therapeutics has secured $1.7 million in series seed funding. The capital is being used to launch AralyteTM, a special diet that helps introduce peanuts to infants at risk of developing peanut allergies. RA Capital Management led the round.